Hepatotoxicity Following Nevirapine-Containing Regimens in Hiv-1-Infected Individuals

Author： de Maat M.M.R.   Mathot R.A.A.   Veldkamp A.I.   Huitema A.D.R.   Mulder J.W.   Meenhorst P.L.   van Gorp E.C.M.   Carlier H.   Beijnen J.H.  

Publisher： Academic Press

ISSN： 1043-6618

Source： Pharmacological Research, Vol.46, Iss.3, 2002-09, pp. : 295-300

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Drug Interaction of Fluvoxamine and Fluoxetine with Nevirapine in HIV-1-Infected Individuals

By de Maat M.M.R.  

Clinical Drug Investigation, Vol. 23, Iss. 10, 2003-01 ,pp. : 629-637

Adis International

Access to resources Recommend Favorite

No relationship between high nevirapine plasma concentration and hepatotoxicity in HIV-1-infected patients naive of antiretroviral treatment or switched from protease inhibitors

By Dailly Eric   Billaud Eric   Reliquet Véronique   Breurec Sébastien   Perré Philippe   Léautez Sophie   Jolliet Pascale   Bourin Michel   Raffi François  

European Journal of Clinical Pharmacology, Vol. 60, Iss. 5, 2004-07 ,pp. : 343-348

Springer Publishing Company

Access to resources Recommend Favorite

Analysis of Severe Hepatic Events Associated with Nevirapine-Containing Regimens: CD4+ T-Cell Count and Gender in Hepatitis C Seropositive and Seronegative Patients

By Torti Carlo  

Drug Safety, Vol. 30, Iss. 12, 2007-01 ,pp. : 1161-1169

Adis International

Access to resources Recommend Favorite

Vaccination in HIV-infected individuals

By Le Corre Nicole   Autran Brigitte  

Future Virology, Vol. 7, Iss. 1, 2012-01 ,pp. : 85-102

Future Medicine

Access to resources Recommend Favorite

Efavirenz-containing regimens superior in HIV-1 infection?

By  

Inpharma, Vol. 1, Iss. 1219, 2000-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite